Literature DB >> 3198770

Delta 4-3-oxosteroid 5 beta-reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis.

K D Setchell1, F J Suchy, M B Welsh, L Zimmer-Nechemias, J Heubi, W F Balistreri.   

Abstract

A new inborn error in bile acid synthesis, manifest in identical infant twins as severe intrahepatic cholestasis, is described involving the delta 4-3-oxosteroid 5 beta-reductase catalyzed conversion of the key intermediates, 7 alpha-hydroxy-4-cholesten-3-one and 7 alpha,12 alpha-dihydroxy-4-cholesten-3-one for chenodeoxycholic and cholic acid synthesis, to the respective 3 alpha-hydroxy-5 beta (H) products. This defect was detected by fast atom bombardment ionization-mass spectrometry from an elevated excretion and predominance of taurine conjugated unsaturated hydroxy-oxo-bile acids. Gas chromatography-mass spectrometry confirmed these to be 7 alpha-hydroxy-3-oxo-4-cholenoic and 7 alpha,12 alpha-dihydroxy-3-oxo-4-cholenoic acids (75-92% of total). Fasting serum bile acid concentrations were greater than 37 mumol/liter; chenodeoxycholic acid was the major bile acid, but significant amounts of allo(5 alpha-H)-bile acids (approximately 30%) were present. Biliary bile acid concentration was less than 2 mumol/liter and consisted of chenodeoxycholic, allo-chenodeoxycholic, and allo-cholic acids. These biochemical findings, which were identical in both infants, indicate a defect in bile acid synthesis involving the conversion of the delta 4-3-oxo-C27 intermediates into the corresponding 3 alpha-hydroxy-5 beta(H)-structures, a reaction that is catalyzed by a delta 4-3-oxosteroid-5 beta reductase enzyme. This defect resulted in markedly reduced primary bile acid synthesis and concomitant accumulation of delta 4-3-oxo-and allo-bile acids. These findings indicate a pathway in bile acid synthesis whereby side chain oxidation can occur despite incomplete alterations to the steroid nucleus, and lend support for an active delta 4-3-oxosteroid 5 alpha-reductase catalyzing the conversion of the delta 4-3-oxosteroid intermediates to the respective 3 alpha-hydroxy-5 alpha(H)-structures.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3198770      PMCID: PMC442799          DOI: 10.1172/JCI113837

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  BILE ACIDS. XXII. ALLOCHOLIC ACID, A METABOLITE OF 5-ALPHA-CHOLESTAN-3-BET-A-OL IN THE RAT.

Authors:  H J KARAVOLAS; W H ELLIOTT; S L HSIA; E A DOISY; J T MATSCHINER; S A THAYER; E A DOISY
Journal:  J Biol Chem       Date:  1965-04       Impact factor: 5.157

2.  On the conversion of cholesterol to 7-alpha,12-alpha-dihydroxycholest-4-en-3-one. Bile acids and steroids 168.

Authors:  H Danielsson; K Einarsson
Journal:  J Biol Chem       Date:  1966-04-10       Impact factor: 5.157

3.  Conversion of cholesterol to bile acids in rat: purification and properties of a delta-4-3-ketosteroid 5-beta-reductase and a 3-alpha-hydroxysteroid dehydrogenase.

Authors:  O Berséus
Journal:  Eur J Biochem       Date:  1967-11

4.  Bile-salt metabolism in the newborn. Measurement of pool size and synthesis by stable isotope technic.

Authors:  J B Watkins; D Ingall; P Szczepanik; P D Klein; R Lester
Journal:  N Engl J Med       Date:  1973-03-01       Impact factor: 91.245

5.  Metabolism of cholest-5-ene-3 beta, 26-diol in the rat and hamster.

Authors:  N Wachtel; S Emerman; N B Javitt
Journal:  J Biol Chem       Date:  1968-10-10       Impact factor: 5.157

6.  12alpha-hydroxylation of 7alpha-hydroxy-4-cholesten-3-one by a reconstituted system from rat liver microsomes.

Authors:  C Bernhardsson; I Björkhem; H Danielsson; K Wikvall
Journal:  Biochem Biophys Res Commun       Date:  1973-10-01       Impact factor: 3.575

7.  Formation and metabolism of 7 alpha-hydroxy-5-alpha-cholestan-3-one and 7 alpha, 12 alpha-dihydroxy-5-alpha-cholestan-3-one in rat liver.

Authors:  I Björkhem; K Einarsson
Journal:  Eur J Biochem       Date:  1970-03-01

8.  Bile acid synthesis in man: metabolism of 7 -hydroxycholesterol- 14 C and 26-hydroxycholesterol- 3 H.

Authors:  K E Anderson; E Kok; N B Javitt
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

9.  Effect of sodium taurolithocholate on bile flow and bile acid exeretion.

Authors:  N B Javitt; S Emerman
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

10.  Enzymatic conversion of a delta-4-3-ketosteroid into a 3-alpha-hydroxy-5-beta steroid: mechanism and stereochemistry of hydrogen transfer from NADPH. Bile acids and steroids 190.

Authors:  O Berséus; L Björkhem
Journal:  Eur J Biochem       Date:  1967-11
View more
  47 in total

Review 1.  The molecular genetics of familial intrahepatic cholestasis.

Authors:  P L Jansen; M Müller
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

2.  Developmental pattern of 3-oxo-delta 4 bile acids in neonatal bile acid metabolism.

Authors:  T Inoue; A Kimura; K Aoki; M Tohma; H Kato
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-07       Impact factor: 5.747

3.  Di- and trihydroxycholestanoic acidaemia with hepatic failure.

Authors:  H Przyrembel; R J Wanders; C W van Roermund; R B Schutgens; G P Mannaerts; M Casteels
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

4.  The effect of disease associated point mutations on 5β-reductase (AKR1D1) enzyme function.

Authors:  Rebekka Mindnich; Jason E Drury; Trevor M Penning
Journal:  Chem Biol Interact       Date:  2010-12-24       Impact factor: 5.192

Review 5.  Fetal and neonatal bile acid synthesis and metabolism--clinical implications.

Authors:  W F Balistreri
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

Review 6.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

Review 7.  Bile acids: chemistry, physiology, and pathophysiology.

Authors:  Maria J Monte; Jose J G Marin; Alvaro Antelo; Jose Vazquez-Tato
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

8.  Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy.

Authors:  H A Lemonde; E J Custard; J Bouquet; M Duran; H Overmars; P J Scambler; P T Clayton
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

9.  Primary ∆4-3-oxosteroid 5β-reductase deficiency: two cases in China.

Authors:  Jing Zhao; Ling-Juan Fang; Kenneth D R Setchell; Rui Chen; Li-Ting Li; Jian-She Wang
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

10.  Diagnosis of the first Japanese patient with 3-oxo-delta4-steroid 5beta-reductase deficiency by use of immunoblot analysis.

Authors:  A Kimura; K H Kondo; K I Okuda; S Higashi; M Suzuki; T Kurosawa; M Tohma; T Inoue; A Nishiyori; M Yoshino; H Kato; T Setoguchi
Journal:  Eur J Pediatr       Date:  1998-05       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.